Visakhapatnam: The Visakhapatnam Covid Clinical Research Center (VCCRC) will be ready to facilitate clinical trials by licensed pharma companies from July.
It is the only center in the two Telugu states, and one among 19 locations in the country, identified by the biotechnology department of the Union ministry of science and technology.
The Centre took up this project as part of the Mission Covid Suraksha (MCS) to indigenously develop and manufacture safe, efficacious, accessible and affordable Covid vaccines to meet the country’s requirements in future. Around 26 crore people have been vaccinated in the country till date.
Andhra Medical College (AMC) here was entrusted with the task of creating infrastructure and manpower required for the VCCRC. The Centre allocated Rs 1.7 crore as a booster fund to set up the centre. Accordingly, the AMC allotted 2,000 square yards of its land at Simhachalam for VCCRC.
Speaking to Deccan Chronicle, AMC principal Dr P.V….
